In the current study, no significant effect of epibatidine (which is an agonist of all nAChR subtypes except α9) on U87MG or patient-derived GBM microsphere cultures was detected in a wide range of concentrations (3 nM–1 μM) (Figure 6). The gene discussed is CHRNA4; the disease is glioblastoma.